EDGAR Filing Documents for 0000950133-05-003150

Form 8-K - Current report:

SEC Accession No. 0000950133-05-003150

Filing Date

2005-07-22

Accepted

2005-07-22 15:14:43

Documents

Period of Report

2005-07-20

Items

Item 1.01: Entry into a Material Definitive Agreement
Item 2.03: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
Item 3.03: Material Modifications to Rights of Security Holders
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq	Description	Document	Type	Size
1	FORM 8-K	w11034e8vk.htm	8-K	28965
2	EXHIBIT 2.1	w11034exv2w1.htm	EX-2.1	554684
3	EXHIBIT 4.1	w11034exv4w1.htm	EX-4.1	18162
4	EXHIBIT 10.1	w11034exv10w1.htm	EX-10.1	107342
5	EXHIBIT 10.2	w11034exv10w2.htm	EX-10.2	25605
	Complete submission text file	0000950133-05-003150.txt		736469

Mailing Address 6611 TRIBUTARY STREET BALTIMORE MD 21224

Business Address 6611 TRIBUTARY STREET BALTIMORE MD 21224 4106316300

GUILFORD PHARMACEUTICALS INC (Filer) CIK: 0000918066 (see all company filings)